Preclinical characterization of JAK1/JAK2 inhibitors for treatment of type 1 diabetes

被引：0
|
作者：
Scott, N. A. [1 ,2 ]
Trivedi, P. M. [1 ,2 ]
Graham, K. L. [1 ,2 ]
Fynch, S. [1 ]
Jenkins, M. R. [3 ]
Kay, T. W. [1 ,2 ]
Thomas, H. E. [1 ,2 ]
机构：
[1] St Vincents Inst, Immunol & Diabet Unit, Fitzroy, Vic, Australia
[2] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic, Australia
[3] Peter MacCallum Canc Ctr, Canc Immunol Res, East Melbourne, Australia
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2016年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
3795
引用
收藏
页码：361 / 361
页数：1
相关论文
共 50 条
  • [31] Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitor
    Ge, Tingting
    Phung, Amber-Lee
    Jhala, Gaurang
    Trivedi, Prerak
    Principe, Nicola
    De George, David J.
    Pappas, Evan G.
    Litwak, Sara
    Sanz-Villanueva, Laura
    Catterall, Tara
    Fynch, Stacey
    Boon, Louis
    Kay, Thomas W.
    Chee, Jonathan
    Krishnamurthy, Balasubramanian
    Thomas, Helen E.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2022, 11 (11)
  • [32] Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors
    Springuel, Lorraine
    Hornakova, Tekla
    Losdyck, Elisabeth
    Lambert, Fanny
    Leroy, Emilie
    Constantinescu, Stefan N.
    Flex, Elisabetta
    Tartaglia, Marco
    Knoops, Laurent
    Renauld, Jean-Christophe
    BLOOD, 2014, 124 (26) : 3924 - 3931
  • [33] Molecular alterations in JAK1 and JAK2 genes in head and neck squamous cell carcinoma
    Carvalho, Thais G.
    Carvalho, Andre Lopes
    Vettore, Andre Luiz
    CANCER RESEARCH, 2012, 72
  • [34] Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis.
    Verstovsek, Srdan
    Kantarjian, Hagop
    Mesa, Ruben A.
    Pardanani, Animesh D.
    Cortes-Franco, Jorge
    Thomas, Deborah A.
    Estrov, Zeev
    Fridman, Jordan S.
    Bradley, Edward C.
    Erickson-Viitanen, Susan
    Vaddi, Kris
    Levy, Richard
    Tefferi, Ayalew
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (12): : 1117 - 1127
  • [35] Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD Mice
    Trivedi, Prerak M.
    Graham, Kate L.
    Scott, Nicholas A.
    Jenkins, Misty R.
    Majaw, Suktilang
    Sutherland, Robyn M.
    Fynch, Stacey
    Lew, Andrew M.
    Burns, Christopher J.
    Krishnamurthy, Balasubramanian
    Brodnicki, Thomas C.
    Mannering, Stuart I.
    Kay, Thomas W.
    Thomas, Helen E.
    DIABETES, 2017, 66 (06) : 1650 - 1660
  • [36] Discovery of CYT387: A potent and selective dual inhibitor of JAK1 and JAK2
    Burns, Christopher J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [37] Selective JAK1 inhibitors for the treatment of inflammatory bowel disease
    Nielsen, Ole Haagen
    Boye, Theresa Louise
    Gubatan, John
    Chakravarti, Deepavali
    Jaquith, James B.
    LaCasse, Eric C.
    PHARMACOLOGY & THERAPEUTICS, 2023, 245
  • [38] A CASE STUDY OF RESENSITIZATION TO RUXOLITINIB, A JAK1/JAK2 INHIBITOR, IN A PATIENT WITH MYELOFIBROSIS (MF)
    Gisslinger, H.
    Skrabs, C.
    Gisslinger, B.
    Schoder, R.
    Muellauer, L.
    Kralovics, R.
    HAEMATOLOGICA, 2013, 98 : 346 - 347
  • [39] Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2
    Luo, Na
    Formisano, Luigi
    Gonzalez-Ericsson, Paula I.
    Sanchez, Violeta
    Dean, Phillip T.
    Opalenik, Susan R.
    Sanders, Melinda E.
    Cook, Rebecca S.
    Arteaga, Carlos L.
    Johnson, Douglas B.
    Balko, Justin M.
    ONCOIMMUNOLOGY, 2018, 7 (06):
  • [40] Identification of selective JAK1 inhibitors for treatment of autoimmune diseases
    Kaila, Neelu
    Vazquez, Michael
    Unwalla, Rayomand
    Strohbach, Joseph
    Trzupek, John
    Han, Seungil
    Robinson, Ralph
    Parikh, Mihir
    Arnold, Eric
    Choi, Chulho
    Drozda, Susan
    Dowty, Martin
    Telliez, Jean-Baptiste
    Hegen, Martin
    Symanowicz, Peter
    Jussif, Jason
    Radi, Zaher
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
12345